Ra Pharmaceuticals Inc
(RARX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 264,992 | 209,822 | 70,381 | 117,812 | 19,386 |
| TOTAL | $274,694 | $212,407 | $72,877 | $119,502 | $20,186 |
| Non-Current Assets | |||||
| PPE Net | 4,732 | 5,165 | 5,606 | 5,537 | 2,143 |
| Intangibles | 0 | 0 | 380 | 445 | 510 |
| Other Non-Current Assets | 4,726 | 1,648 | 1,334 | 1,334 | 1,503 |
| TOTAL | $9,458 | $6,813 | $7,320 | $7,316 | $4,156 |
| Total Assets | $284,152 | $219,220 | $80,197 | $126,818 | $24,342 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,817 | 3,245 | 4,348 | 3,252 | 1,319 |
| Accrued Expenses | 15,178 | 6,477 | 3,937 | 3,182 | 1,274 |
| Other current liabilities | N/A | N/A | N/A | N/A | 2,620 |
| TOTAL | $18,579 | $10,201 | $8,614 | $6,737 | $6,938 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 479 | 329 | 303 | 1,725 |
| Other Non-Current Liabilities | 3,438 | 0 | 0 | 0 | 53,675 |
| TOTAL | $3,459 | $1,901 | $2,399 | $2,859 | $54,603 |
| Total Liabilities | $22,038 | $12,102 | $11,013 | $9,596 | $61,541 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,329 | 42,189 | 32,287 | 22,546 | N/A |
| Common Shares | 47 | 42 | 23 | 23 | 1 |
| Retained earnings | -290,845 | -188,157 | -123,214 | -68,764 | -39,900 |
| TOTAL | $262,114 | $207,118 | $69,184 | $117,222 | $-37,199 |
| Total Liabilities And Equity | $284,152 | $219,220 | $80,197 | $126,818 | $24,342 |